Northstar Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Northstar Advisory Group's LLY Position: Q2 2026 in Review
Northstar Advisory Group increased its Eli Lilly (LLY) stake by 328% in Q2 2026, buying an estimated $2.25M and bringing the position to 2,877 shares worth $3.45M. The position accounts for 1.07% of the portfolio, ranked #25.
Northstar Advisory Group first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.03M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Northstar Advisory Group held 2,877 shares of Eli Lilly worth $3.45M as of Q2 2026.
- Northstar Advisory Group bought 2,205 Eli Lilly shares in Q2 2026, an estimated $2.25M.
- Eli Lilly made up 1.07% of Northstar Advisory Group's portfolio in Q2 2026, its #25 holding.
- Northstar Advisory Group first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- Northstar Advisory Group's Eli Lilly position peaked at $5.03M in Q4 2025.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Northstar Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.